Hikari Medical Technologies, LLC

From the company

Hikari Medical Technologies is developing NAGOMI™, a noninvasive precision dosing platform combining light-enabled drug release and real-time monitoring for safer, more controllable therapies. The platform integrates monitorable carriers, a light-enabled wearable, and optical feedback in one therapeutic interface. The company has preclinical programs in hepatorenal syndrome, pulmonary hypertension, multiple myeloma, and Parkinson's disease, and collaborates with pharma, government innovation programs, and translational labs.